Previous 10 | Next 10 |
Earnings for the S&P 500, according to Howard Silverblatt’s work at S&P, are expected to rise 7.7% in 2022. Growth stocks were grossly overvalued going into that bear market and they took the brunt of the damage. Real estate did well last week with rates falling bac...
From the November peak to the recent trough, U.S. large cap growth stocks lost more than 30%, a decline on par with the pandemic induced bear market. Growth is still trailing the S&P 500 by roughly 10% and nearly 17% versus comparable value indexes. As economic growth slows, i...
Growth stocks are under acute pressure as rising interest rates change the dynamics that drive equity valuations. Market corrections are always painful, but investors in growth equities have suffered a particularly harsh blow this year. This year’s market correction reflect...
MSCI U.S. Growth has underperformed its Value counterpart by 16% in the first 4 months of 2022 and had a tough end to 2021 as well. The fact that growth traps are more painful than value traps is, in one sense, not really a surprise. Value stocks are already companies that investors d...
Stocks had a ripsnorter of a rally last week and a lot of people are pondering the question in the title over this long weekend. Sentiment is certainly negative right now by several measures. Sentiment surveys (AAII, Investor’s Intelligence, etc.) are universally negative becau...
How similar will the next three or five years look from the years that immediately preceded the pandemic? And what are the implications for us as global equity investors? We don’t expect anything like the hyperinflation and stagflation we experienced in the 1970s; our outlook s...
Value continues to trounce growth stocks within the style asset class across all market caps, and the longer-term returns tell us that growth might continue to lag for some time. It’s impossible to say how long the style “alpha” will be sustained. Growth stocks ha...
Our macroeconomic forecasting team assesses how the war and latest survey data have altered the economic outlook, policymaking and recession risks. Global growth was dragged lower, principally by steep contractions in Russia and mainland China. Barring the initial COVID-19 outbreak, M...
The map of the Asset Allocation Committee’s market views is a buzz of activity this quarter. Coming into 2022, we anticipated slower growth compared with the steep recovery levels of 2021 and inflation that was declining but persistent—and problematic due to its origins ...
With oil prices spiking and investors avoiding volatile names, only a few themes have worked: energy and defensive stocks. With economic growth likely to slow and earnings growth harder to come by, companies able to grow earnings should garner renewed interest. To the extent reces...
News, Short Squeeze, Breakout and More Instantly...
Innovator IBD ETF Leaders ETF Company Name:
LDRS Stock Symbol:
NYSE Market:
CHICAGO, July 20, 2021 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (Innovator) today announced the scheduled liquidation of the Innovator IBD® ETF Leaders ETF (NYSE Arca: LDRS) (the “Fund”). Based upon the recommendation of Innovator, the Fund’s i...
New ETFs provide US Technology, and US Small Cap exposures up to a cap, with 15% downside buffers over a one-year Outcome Period The only Buffer ETFs available based on the Nasdaq 100, and Russell 2000 Indexes Innovator's Defined Outcome ETFs are the subject of a patent application filed wi...
New ETFs will provide US Technology, US Small Cap, International Developed and Emerging Markets exposures up to a cap, with 15% downside buffers over a one-year Outcome Period The only Buffer ETFs available based on the Nasdaq 100, Russell 2000, MSCI EAFE and MSCI Emerging Markets Indexes I...